Arix Bioscience Plc - Company Profile
Powered by 
All the sales intelligence you need on Arix Bioscience Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Arix Bioscience Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Arix Bioscience Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Arix Bioscience Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 01 Nov 2023 | RTW Biotech to Acquire 26.6% Stake in Arix Bioscience from Acacia Research for 57.35 Million | Acquisition |
RTW Biotech Opportunities Ltd
|
Arix Bioscience Plc |
| 16 May 2023 | Ensoma Raises Additional USD50 Million in Extended Series B Financing | Venture Financing |
Kite Pharma Inc
Mirae Asset Securities Co., Ltd.
Qatar Investment Authority
Alexandria Venture Investments, LLC
F-Prime Inc
Delos Capital LLC
Arix Bioscience Inc
5AM Venture Management LLC
Symbiosis
Solasta Ventures
Cormorant Asset Management LLC
Bill & Melinda Gates Foundation
Takeda Ventures Inc
Viking Global Investors LP
Fred Hutchinson Cancer Research Center
Catalio Capital Management LP
Bioluminescence Ventures
|
Ensoma Inc
|
| 26 Apr 2023 | Evommune Raises USD50 Million in Series B Financing | Venture Financing |
Pivotal BioVenture Partners LLC
Arix Bioscience Inc
Symbiosis LLC
Andera Partners
Amplitude Ventures Inc
EQT Life Sciences
|
Evommune Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer